日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

剂量递增的白细胞介素-2 疗法治疗成人和儿童难治性慢性移植物抗宿主病

Jennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G Reynolds, Sharmila C Rai, Kelly Verrill, Michelle A Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P Alyea 3rd, Philippe Arma

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

硼替佐米为基础的免疫抑制方案在减低强度预处理造血干细胞移植后的疗效:随机II期临床试验结果

Koreth, John; Kim, Haesook T; Lange, Paulina B; Poryanda, Samuel J; Reynolds, Carol G; Rai, Sharmila Chamling; Armand, Philippe; Cutler, Corey S; Ho, Vincent T; Glotzbecker, Brett; Yusuf, Rushdia; Nikiforow, Sarah; Chen, Yi-Bin; Dey, Bimalangshu; McMasters, Malgorzata; Ritz, Jerome; Blazar, Bruce R; Soiffer, Robert J; Antin, Joseph H; Alyea, Edwin P 3rd